Abstract
Objectives: To study the effects of all-trans-retinoic acid (ATRA), we determined the proliferation and cytokine production by peripheral blood mononuclear cells (PBMCs) and CD4+ T cells in healthy volunteers and patients with rheumatoid arthritis (RA), and explored the possibility of using ATRA as a therapeutic agent for autoimmune diseases. Methods: Proliferation of these cells was determined by modified MTT assay, and expression of CC chemokine receptors 4 (CCR4) and CCR5 was determined by flow cytometry. Production and expression of interferon (IFN)-γ, interleukin (IL)-2, IL-4, and tumor necrosis factor (TNF)-α was determined by Enzyme-Linked Immunosorbent Assay (ELISA) and reverse transcription-polymerase chain reaction (RT-PCR). The presence of STAT6 protein was determined by Western blot analysis. Results: ATRA did not affect the proliferation or production of IL-2 and IL-4. We did not detect STAT6 protein, and saw no evidence of the differentiation of PBMCs to Th1 or Th2 cells. In contrast, ATRA suppressed the production of IFN-γ and TNF-α significantly. There were no significant differences between the healthy volunteers and RA patients. Conclusions: ATRA was demonstrated to affect the cytokine production of IFN-γ and TNF-α. ATRA might be useful in the treatment of autoimmune diseases such as RA.
Similar content being viewed by others
References
Romagnani S (1995) Biology of human TH1 and TH2 cells. J Clin Immunol 15:121–129
Hayashi M, Martinez OM, Garcia-Kennedy (1995) Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation 60:1538–1553
Lafaille JJ (1998) The role of helper T cell subset in autoimmune disease. Cytokine Growth Factor Rev 9:139–151
Barton MT, Vitetta ES (1990) Interleukin-4 induces changes in the chromatin structure of the Ig switch region in resting B cells before switch recombination. J Exp Med 172:375–378
Ichiki T, Takahashi W, Watanabe T (1993) Regulation of the expression of human C germline transcript. J Immunol 150:5408–5417
Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397–440
Feldmann M, Brennan FM, Maini RN (1996) Rheumatoid arthritis. Cell 85:307–310
Mathew JS, Sharma RP (2000) Effect of all-trans-retinoic acid on cytokine production in a murine macrophage cell line. Int J Immunopharmacol 22:693–706
Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G (1991) Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO J 10:4025–4031
Ishiyawa M, Hideyuki T, Shiga M (1996) A combined assay of cell viability and in vitro cytotoxity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 19:1518–1520
Diefenbach A, Schindler H, Rollinghoff M, Yokoyama WM, Bogdan C (1999) Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science 284:951–955
Jiang XL, Dillehay DL, Everson MP, Tilden AB, Lamon EW (1992) Potentiation of IL-2-induced T-cell proliferation by retinoids. Int J Immunopharmacol 14:195–204
Sidell N, Ramsdell F (1988) Retinoic acid upregulates interleukin-2 receptors on activated human thymocytes. Cell Immunol 115:299–309
Felli MP, Vacca A, Meco D, Screpanti I, Farina AR, Maroder M, Martinotti S, Petrangeli E, Frati L, Gulino A (1991) Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. Mol Cell Biol 11:4771–4778
Kinoshita K, Yoo BS, Nozaki Y, Sugiyama M, Ikoma S, Ohno M, Funauchi M, Kanamaru A (2003) Retinoic acid reduces autoimmune renal injury and increases survival in NZB/WF1 mice. J Immunol 170:5793–5798
Racke MK, Burnett D, Pak SH, Albert PS, Cannella B, Raine CS, McFarlin DE, Scott DE (1995) Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 154:450–458
Kaplan MH, Schindler U, Smiley ST, Grusby MJ (1996) Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313–319
Konta T, Xu Q, Furusu A, Nakayama K, Kitamura M (2001) Selective roles of retinoic acid receptor and retinoid X receptor in the suppression of apoptosis by all-trans-retinoic acid. J Biol Chem 16:12697–12701
Siebenlist U, Franzoso G, Brown K (1994) Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10:405–455
Gerli R, Bistoni O, Russano A, Fiorucci S, Borgato L, Cesarotti ME, Lunardi C (2002) In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease. Clin Exp Immunol 129:549–555
Steiner G, Tohidast-Akrad M, Witzmann G, Vesely M, Studnicka-Benke A, Gal A, Kunaver M, Zenz P, Smolen JS (1999) Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology 38:202–213
Canete JD, Martinez SE, Farres J, Sanmarti R, Blay M, Gomez A, Salvador G, Munoz-Gomez J (2000) Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis 59:263–268
Dayer JM (2002) Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis? J Rheumatol 65:10–15
Bathon JM, Martin RW, Fleischmann RM et al (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343:1586–1593
Hallegua DS, Weisman MH (2002) Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases. Ann Rheum Dis 61:960–967
Acknowledgment
We are grateful to K. Niki and K. Furukawa for their excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nozaki, Y., Tamaki, C., Yamagata, T. et al. All-trans-retinoic acid suppresses interferon-γ and tumor necrosis factor-α; a possible therapeutic agent for rheumatoid arthritis. Rheumatol Int 26, 810–817 (2006). https://doi.org/10.1007/s00296-005-0076-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-005-0076-1